Dr Mark Treherne


Dr Mark Treherne was appointed chief executive in August 2012. A research scientist with a PhD in Pharmacology from Cambridge University, he has more than 25 years industrial experience in the discovery of novel treatments for diseases of the nervous system.

Previous roles in government

  1. Chief Executive

    • 2012 to 2016